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Abstract:
Mitochondrial dysfunction contributes to cardiac ischemia–reperfusion
(IR) injury but volatile anesthetics (VA) may alter mitochondrial function to
trigger cardioprotection. We hypothesized that the VA isoflurane (ISO)
mediates cardioprotection in part by altering the function of several
respiratory and transport proteins involved in oxidative phosphorylation
(OxPhos). To test this we used fluorescence spectrophotometry to measure
the effects of ISO (0, 0.5, 1, 2 mM) on the time-course of interlinked
mitochondrial bioenergetic variables during states 2, 3 and 4 respiration in
the presence of either complex I substrate K+-pyruvate/malate (PM) or
complex II substrate K+-succinate (SUC) at physiological levels of extramatrix free Ca2 + (~ 200 nM) and Na+ (10 mM). To mimic ISO effects on
mitochondrial functions and to clearly delineate the possible ISO targets, the
observed actions of ISO were interpreted by comparing effects of ISO to
those elicited by low concentrations of inhibitors that act at each respiratory
complex, e.g. rotenone (ROT) at complex I or antimycin A (AA) at complex
III. Our conclusions are based primarily on the similar responses of ISO and
titrated concentrations of ETC. inhibitors during state 3. We found that with
the substrate PM, ISO and ROT similarly decreased the magnitude of state 3
NADH oxidation and increased the duration of state 3 NADH oxidation, ΔΨ m
depolarization, and respiration in a concentration-dependent manner,
whereas with substrate SUC, ISO and ROT decreased the duration of state 3
NADH oxidation, ΔΨm depolarization and respiration. Unlike AA, ISO reduced
the magnitude of state 3 NADH oxidation with PM or SUC as substrate. With
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substrate SUC, after complete block of complex I with ROT, ISO and AA
similarly increased the duration of state 3 ΔΨm depolarization and respiration.
This study provides a mechanistic understanding in how ISO alters
mitochondrial function in a way that may lead to cardioprotection.
Keywords: Volatile anesthetic; Isoflurane; Mitochondrial bioenergetics;
Electron transport chain; Cardiac IR injury; Cardioprotection

1. Introduction
Mitochondria are primary mediators of cardiac ischemia–
reperfusion (IR) injury [1], [2], [3] and [4]; they are also important
targets for volatile anesthetic (VA)-induced cardioprotection against IR
injury [3], [5], [6], [7], [8], [9], [10], [11] and [12]. Cardioprotection
by a VA can be instituted either before the onset of ischemia
(anesthetic pre-conditioning: APC) or at the onset of reperfusion
(anesthetic post-conditioning: APOC) [13] and [14]. Regardless of the
cardioprotective strategy, VAs exert effects on mitochondrial function.
Mitochondrial failure consequent to bioenergetic dysfunction
leads to cell damage during IR but specific components of the
mitochondrial bioenergetic mechanisms may be targets for the actions
of VAs that underlie APC or APOC against IR injury. Volatile
anesthetics, including isoflurane (ISO) are known to mediate
cardioprotection against IR injury, in part, by attenuating function of
the electron transport chain (ETC) protein complex I (NADH
oxidoreductase) and by triggering mild ROS production, a critical
mediator for cellular protection [15], [16], [17] and [18]. The
mechanisms of ISO and other VAs to alter mitochondrial function and
confer cardioprotection via their actions on ETC complexes and other
mitochondrial transport proteins, however, are not well understood.
It may seem incongruous at first that IR-induced injury
ultimately leads to dysfunction of mitochondrial respiration but, on the
other hand, attenuation of mitochondrial respiration might minimize
mitochondrial injury and reduce cell death during cardiac IR injury
[19] and [20]. Thus, an understanding of ISO-induced actions on
selective mitochondrial proteins, including the ETC complexes and
transport proteins that are crucial for oxidative phosphorylation
(OxPhos), is essential in elucidating the mechanisms of ISO-induced
cardioprotection against IR injury.
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In our recent study in isolated mitochondria [8] in which we
demonstrated that ISO attenuates Ca2 + extrusion by the mitochondrial
Na+/Ca2 + exchanger, we also found that ISO caused a concentrationdependent decrease in the rate of state 3 NADH oxidation and ADP
phosphorylation with the complex I substrate pyruvate/malate (PM).
Complex I was first suggested as a site for VA effects [21] and [22];
this was supported by later findings [23] and [24]. Our initial observed
effects of ISO [8] to increase the duration of state 3 NADH oxidation
and ΔΨm depolarization also supported complex I as a site of action,
but this could alternatively have been due to inhibition of other ETC.
complexes downstream of complex I, e.g., complexes III (ubiquinol
cytochrome c oxidoreductase), IV (cytochrome c oxidase) and V (F1F0
ATP synthase), or complex II (succinate dehydrogenase) and transport
proteins (e.g. adenine nucleotide transporter, ANT); alternatively, as
has been reported, ISO might act as an uncoupling agent by
promoting a proton leak [25] that could lead to mild ΔΨm
depolarization.
Because our understanding of the mechanisms of ISO-targeted
mitochondrial interventions is not well defined, we compared the ISO
effects to those elicited by low concentrations of known site-specific
inhibitors of mitochondrial proteins. That is, we explored the potential
mitochondrial targets of ISO by comparing its concentrationdependent effects with the concentration-dependent effects of known
inhibitors of ETC. complexes and mitochondrial transport proteins to
identify, and also rule out, possible ISO targets. In this way we hoped
to better understand how VA-induced modification of mitochondrial
bioenergetics can contribute to cardioprotection. To carry out our aims
we used isolated cardiac mitochondria energized with substrates K+pyruvate/malate (PM), K+-succinate (SUC) or SUC + Rotenone (ROT,
1 μM). Low concentrations of ROT antimycin A (AA), oligomycin
(OMN), and atractyloside (ATR) were used to stepwise attenuate
complexes I, III, V and ANT function, respectively; low concentrations
of malonate (MAL) and potassium cyanide (KCN) were used in some
experiments to attenuate functions of complexes II and IV,
respectively.
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2. Materials and methods
2.1. Mitochondrial isolation
Mitochondria were freshly isolated from hearts of Wistar rats
(300–350 g) using protocols approved by the Medical College of
Wisconsin Institutional Animal Care and Use Committee (IACUC) as
described previously [8]. Briefly, rats were anesthetized with an
intraperitoneal injection of inactin (150 mg/kg), and the ventricles
were excised and placed in an ice-cold isolation buffer that contained
(in mM): 200 mannitol, 50 sucrose, 5 KH2PO4, 5 MOPS, 1 EGTA and
0.1% BSA, with pH adjusted to 7.15 with KOH. The ventricles were
minced in the presence of 5 U/ml protease (Bacillus licheniformis,
Sigma) followed by differential centrifugation. All isolation procedures
were carried out at 4 °C. Mitochondrial protein content was
determined by the Bradford method [26]. The final mitochondrial
pellet was resuspended in isolation buffer and kept on ice. All
chemicals were procured from Sigma (St. Louis, MO, USA), unless
stated otherwise.

2.2. Measure of mitochondrial redox state (NADH)
NADH autofluorescence was measured in the mitochondrial
suspension during states 2, 3 and 4 respiration using fluorescence
spectrophotometry at excitation wavelength 350 nm and emission
wavelengths 395 nm and 456 nm (Photon Technology International,
Birmingham, NJ), as we have described before [8], [27], [28],
[29] and [30]. At the end of each experiment (390 s), maximal (fully
reduced) NADH (high NADH/NAD+) was determined with 1 μM ROT,
which completely blocks electron transport via FeS centers in complex
I at the ubiquinone (Q) binding site so that proton pumping from
NADH cannot occur; minimal (fully oxidized) NADH (low NADH/NAD+)
was determined with 20 μM trifluorocarbonylcyanidephenylhydrazone
(FCCP), which induces maximal proton leak, and causes an increase in
proton pumping and electron transfer between ETC complexes. The
ratio of emission fluorescence (456/395) was normalized between the
fully oxidized (with FCCP) state to the fully reduced (with ROT) state to
represent % NADH as the total pool of NADH + NAD+.
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2.3. Measure of mitochondrial membrane potential
(ΔΨm)
ΔΨm was measured in the mitochondrial suspension during
states 2, 3 and 4 respiration by fluorescence spectrophotometry using
the fluorescent dye tetramethyl-rhodamine methyl ester (1 μM TMRM;
Molecular Probes, Eugene, OR) at excitation wavelengths 546 nm and
573 nm and emission wavelength 590 nm [31], as we have described
[29]. TMRM is a ratiometric, membrane potential sensitive, cationic
fluorophore that equilibrates across the inner mitochondrial membrane
(IMM) based on its electrochemical potential. ΔΨm measurements
followed the same time-line protocol as NADH measurements except
that the respiratory uncoupler carbonyl cyanide mchlorophenylhydrazone (4 μM CCCP) was used to fully depolarize ΔΨm.
The ratio of excitation wavelengths (546/573) at any time point was
plotted as a percent of maximum fluorescence (100%) obtained by
maximal depolarization with CCCP.

2.4. Measure of mitochondrial O2 consumption
Mitochondrial O2 consumption rate (respiration) was measured
using a Clark-type O2 electrode (System S 200A; Strathkelvin
Instruments, Glasgow, UK) as we have described before [8], [30],
[32] and [33]. Functional integrity of mitochondria was determined by
the respiratory control index (RCI), defined here as the ratio of state 3
(after added ADP) to state 4 respiration (after complete
phosphorylation of the added ADP). Only mitochondrial preparations
with RCIs ≥ 6, measured with PM, were used to conduct further
experiments.

2.5. Protocol
Measures of the three bioenergetic variables (NADH, ΔΨm, and
respiration) were conducted with mitochondria (0.5 mg/ml) suspended
in respiration buffer that contained (in mM): 130 KCl, 10 NaCl, 0.5
CaCl2, 5 K2HPO4, 20 MOPS, 1 EGTA and 0.1% BSA at pH 7.15 adjusted
with KOH, at room temperature (25 °C). NADH, ΔΨm, and respiration
were monitored under complex I-linked substrate (10 mM PM) or
complex II-linked substrate (10 mM SUC) during respiratory states 2
(before adding ADP), 3 (during phosphorylation of 250 μM ADP), and 4
(after complete phosphorylation of the ADP). Along with drug free
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controls (0.1% DMSO), either of three concentrations of ISO (0.5, 1,
2 mM) or several titrated low concentrations of respiratory complex
inhibitors (e.g. 30, 50, 80, 120, 150 nM ROT; 25, 75, 85, 100, 110 nM
AA) were added to the buffer after adding the substrate, followed by
ADP. All drugs were dissolved in DMSO (0.1%). The appropriate
volumes of ISO stock solutions dissolved in DMSO were prepared in
tightly sealed glass vials and specific volumes from these vials were
added to the experimental buffer (1 ml) to obtain the desired ISO
concentrations (i.e. 0.5, 1 and 2 mM). ISO, 0.5 mM, is equivalent to
approximately 1.4% atm at 25 °C with an estimated 1.3 minimum
alveolar concentration (MAC) for rats [23]. To confirm the actual
concentrations of ISO in each mitochondrial suspension, an aliquot of
isoflurane in solution from each vial was obtained and measured by
gas chromatography at the beginning (100 s) and end of each
experiment (500 s). For added ISO, the measured values varied within
± 10% of their initial prepared values of 0.5, 1, 1.5 and 2 mM. The
time-course protocol consisted of the following: (1) 0 s, addition of
mitochondrial sample into the respiration buffer and start of recording;
(2) 30 s, introduction of the substrate (PM or SUC or SUC + ROT)
(1 μM; high concentration that completely blocks electron flow from
complex I) (state 2); (3) 90 s, addition of either of DMSO, ISO or
other mitochondrial protein inhibitors, and (4) 150 s, addition of ADP
(state 3).
Adding substrate PM or SUC provided for forward electron
transfer from complex I or II through complex IV, respectively, and
only reverse electron transfer from complex II to I with SUC. Substrate
SUC with a complete block of complex I by ROT (1 μM) allowed for
forward electron transfer only from complex II through IV. Sites of
inhibition by blockers of each of the five respiratory complexes, and
ANT, as well as how modulation of ΔΨm and matrix pH are all involved
in OxPhos are shown schematically (Fig. 1).
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Fig. 1.

Schema depicting the mitochondrial electron transport chain (ETC) protein

complexes of the mitochondrial inner membrane (IMM), along with their specific
inhibitors: rotenone (ROT), malonate (MAL), antimycin A (AA), potassium cyanide
(KCN), oligomycin (OMN), and atractyloside (ATR). Reducing equivalents, NADH and
FADH2, are generated via the tricarboxylic acid (TCA) cycle in the matrix, while
electrons are transferred through the complexes to the final O2 acceptor. At complex
IV, coupled with this transfer is the pumping of protons (H+) into the intermembrane
space (IMS) by complex I, complex III, and complex IV, which generate the H+
gradient used by ATP synthase (complex V) to phosphorylate ADP to ATP. Depending
on the substrate used, K+-pyruvate/malate (PM) or K+-succinate (SUC), isolated
mitochondria respire differentially using NADH and FADH2 to produce ATP; this is
coupled to forward or reverse electron transfer (FET or RET) depending on the
reduction potential across each complex and across the IMM. ( ) represents potential
targets of isoflurane (ISO) on the ETC. components explored in this study.

2.6. Data analysis and statistics
Traces are representative of the mean of three different
mitochondrial preparations, each with three replicate recordings.
Where appropriate, data are represented as mean ± SD of three
independent experiments. All data were compiled using Microsoft Excel
and analyzed using one-way ANOVA (analysis of variance) with
Turkey's post-hoc test for significance of means. Differences with
P < 0.05 (two-tailed) were considered significant.
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3. Results
3.1. Effect of isoflurane vs. respiratory inhibitors on
mitochondrial redox state (NADH)
Time-dependent effects of DMSO (vehicle) and graded
concentrations of ISO, complex I (ROT), or complex III (AA) inhibitors
in the presence of the substrate PM or SUC during states 2, 3 and 4
are shown in Fig. 2A–F. The insets show summaries of their effects on
the duration of ADP-induced state 3 NADH oxidation (S3 time, s). ISO,
ROT, and AA each had no effect on resting state 2 NADH. With the
complex I substrate PM, ISO caused pronounced concentrationdependent decreases in state 3 NADH oxidation with respect to state 2
NADH after adding ADP: 32 ± 7%, 27 ± 5% and 21 ± 5% at 0.5, 1
and 2 mM ISO, respectively, vs. 42 ± 4% with DMSO. ISO also
significantly increased the duration of state 3 NADH oxidation:
50 ± 4 s, 66 ± 6 s and 103 ± 8 s at 0.5, 1 and 2 mM, respectively, vs.
41 ± 5 s for DMSO (Fig. 2A inset).
To deduce if ISO decreased state 3 NADH oxidation by an action
on complex I, the changes in NADH induced by ISO during state 3 with
substrate PM were compared to the effects of titrated, low
concentrations of the complex I inhibitor ROT (Fig. 2B). These data
showed, similar to ISO, that ROT attenuated the magnitude of state 3
NADH oxidation in a concentration-dependent manner: 35 ± 5%;
25 ± 6%; and 14 ± 4% at 20, 30 and 50 nM, respectively, vs.
41 ± 4% for DMSO. Also like ISO, ROT caused a concentrationdependent increase in the duration of state 3 NADH oxidation (Fig. 2B
inset).
To determine if ISO-induced increases in the duration of state 3
NADH oxidation might also result from reduced proton pumping and
electron transfer downstream from complex I, NADH oxidation was
assessed with titrated, low concentrations of the complex III blocker
AA (see Fig. 1). AA caused concentration-dependent increases in the
duration of state 3 NADH oxidation (Fig. 2C; inset), but unlike ISO and
ROT, it did not decrease the magnitude of state 3 NADH oxidation.
These data indicated that with PM as substrate, ISO decreased the
extent and increased the duration of state 3 NADH oxidation similar to
that of ROT, while it only increased the duration of state 3 NADH
oxidation similar to that of AA. This indicated that both complexes I
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and III might be functional targets for ISO to retard restoration of the
redox state (Fig. 7A).

Fig. 2.

Normalized mitochondrial redox state (NADH/NADH + NAD+) during states

2, 3 and 4 respiration with different substrates and either ISO or a blocker of ETC
complexes. State 2 was induced with 10 mM PM (A–C) or SUC (D–F) and state 3 with
250 μM ADP; state 4 is after phosphorylation of all ADP to ATP. ISO, ROT, or AA was
added after PM or SUC and before ADP. ADP induced a transient decrease in the
reduced state of NADH. The insets summarize effects of ISO compared to ROT and AA
on duration of ADP-induced state 3 NADH oxidation (S3 time, s). Note similarities and
differences of responses to each drug. NADH transients were normalized on a scale of
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0–1, i.e. between fully oxidized to fully reduced states by adding excess FCCP or ROT,
respectively. Data represent mean ± SD of 3 replicates.

To test if the ISO-induced changes in the extent and duration of
state 3 NADH oxidation could also result from reduced inward
translocation of ADP in exchange for ATP extrusion (Fig. 1), NADH
oxidation was measured with low concentrations (0.25 to 1 μM) of the
ANT inhibitor, ATR. But, unlike ISO, ATR caused concentrationdependent decreases in both the extent and duration of state 3 NADH
oxidation (data not shown); together these findings suggested that
there was reduced ADP entry and availability during state 3 to oxidize
NADH. The complex IV blocker KCN at low titrated concentrations (up
to 1 μM) did not exhibit effects similar to ISO on any of the
mitochondrial bioenergetic variables with any substrate tested (data
not shown).
We tested further if the prolonged effects of ISO on the duration
of NADH oxidation with the substrate PM during state 3 were different
from those elicited by the complex II substrate SUC (Fig. 2D) and how
these responses compared with the effects of 30–150 nM ROT
(Fig. 2E) or 100 and 125 nM AA (Fig. 2F). With the substrate SUC,
adding ADP prolonged the duration of NADH oxidation substantially
more than with the substrate PM (Fig. 2D vs. A). ISO tended to only
slightly reduce the magnitude of oxidation but to markedly decrease
the duration of NADH oxidation (Fig. 2D inset). Because ROT
attenuates both forward and reverse electron transfer through
complex I, enhancing attenuation of proton pumping and electron
transfer by ROT or ISO leads to less oxidation of NADH during state 3.
ROT had a greater effect than ISO on both the extent and duration of
NADH oxidation (Fig. 2E vs. D) suggesting that ISO may attenuate
complex I function somewhat differently than ROT, which blocks
electron transfer via a FeS centers at the Q binding site in complex I.
In contrast to the effects of ISO and ROT on attenuating state 3induced oxidation of NADH with the substrate SUC, AA did not change
the extent or duration of NADH oxidation (Fig. 2F) when compared to
DMSO. Thus, these results suggested that ISO-induced effects on
NADH redox state were mediated by attenuating complex I electron
transfer, which in turn impeded proton pumping by NADH.
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3.2. Effect of isoflurane vs. respiratory inhibitors on
mitochondrial membrane potential (ΔΨm)
Time-dependent effects of DMSO (vehicle) and graded
concentrations of ISO, complex I (ROT), or complex III (AA) inhibitors
on ΔΨm in the presence of PM or SUC during respiratory states 2, 3
and 4 are shown in Fig. 3A–F. The insets show summaries of their
effects on the duration of ADP-induced depolarization of ΔΨm (S3 time,
s). ISO, ROT and AA had no effect on resting state 2 ΔΨm. Adding ADP
caused a sudden, partial, and reversible ΔΨm depolarization in all
groups because of the transiently smaller charge and pH gradients
across the IMM due to the stimulation of respiration. With the complex
I substrate, PM, ISO significantly increased the duration of state 3
depolarization of ΔΨm, i.e. by 45 ± 4 s, 81 ± 7 s and 133 ± 7 s at 0.5,
1 and 2 mM, respectively, vs. 38 ± 3 s for DMSO (Fig. 3A). With the
substrate PM, compared to DMSO, adding ADP after ISO, ROT, or AA
caused a delay in state 3 ΔΨm repolarization (Fig. 3A,B,C).
Like ISO, ROT had similar effects on the duration of state 3 ΔΨm
depolarization (Fig. 3A,B insets) and NADH oxidation (Fig. 2A,B insets)
and on the increase in the magnitude of state 3 ΔΨm depolarization;
this was likely due to attenuation of complex I electron transfer and
proton pumping during state 3. Like ISO (Fig. 3A inset), ROT and AA
caused concentration-dependent increases in the duration of state 3
ΔΨm depolarization (Fig. 3B,C insets). The observed ISO-induced
increases in the extent and the duration of state 3 ΔΨm depolarization
(Fig. 3A) were consistent with the observed ISO-induced decrease in
the extent and increase in the duration of state 3 NADH oxidation
(Fig. 2A).
Unlike ISO with the substrate PM, and as observed with NADH,
ATR (0.5–1 μM) caused a concentration-dependent attenuation of the
ADP-induced decrease in ΔΨm, likely due to reduced ADP translocation
through ANT (data not shown); Thus, the marked differences in ISO
and ATR responses suggested again that the effects of ISO were not
mediated via ANT.

Biochimica et Biophysica Acta: Bioenergetics, Vol 1837, No. 3 (March 2014): pg. 354-365. DOI. This article is © Elsevier
and permission has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant
permission for this article to be further copied/distributed or hosted elsewhere without the express permission from
Elsevier.

12

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Fig. 3.

Normalized mitochondrial membrane potential (ΔΨm) during states 2, 3 and

4 respiration with different substrates and after adding either ISO or a blocker of ETC
complexes. ISO, ROT, or AA was given after PM (A–C) or SUC (D–F), and before ADP,
which induced a transient depolarization. The insets summarize effects of ISO
compared to ROT and AA on duration of ADP-induced state 3 decreases in ΔΨm (S3
time, s). Note similarities and differences of responses to each drug. ΔΨm transients
were normalized with respect to maximal (100%) depolarization obtained with added
CCCP. Data represent mean ± SD of 3 replicates.
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Similar to the NADH measurements (Fig. 2), we also compared
the effects of ISO, ROT, and AA (Fig. 3D,E,F), respectively, on
changing the extent and duration of ΔΨm depolarization in the
presence of the complex II substrate SUC during states 2, 3 and 4.
ISO, ROT and AA had no effects on resting state 2 ΔΨm. Adding ADP in
the ISO and ROT groups caused small decreases in the magnitude of
ΔΨm depolarization (Fig. 3D,E) and significant concentrationdependent decreases in the duration of state 3 ΔΨm (Fig. 3D,E insets).
In contrast, AA caused concentration-dependent increases in the
duration of ADP-induced ΔΨm depolarization (Fig. 3F and inset). The
similarity of the concentration-dependent effects of ISO vs. ROT and
AA (Fig. 3A–C) on the duration of the transient ΔΨm depolarization
during state 3 duration (Fig. 3A inset) with NADH-linked substrate PM
supports the notion that complexes I and III are targets for attenuated
mitochondrial function by ISO. In contrast, giving AA in the presence
of SUC did not mimic the effects of ISO on the duration of state 3 ΔΨm
depolarization (Fig. 3D vs. 3 F).
Because the state 3 effects on the duration of ΔΨm
depolarization for ISO were similar to those of ROT, but somewhat
dissimilar to AA in the presence of substrate SUC (Fig. 3D vs. E and F),
we conducted additional experiments in which complex I was
completely blocked by 1 μM ROT before adding SUC; this was followed
by addition of ISO or AA. Under these conditions both ISO and AA
caused increases in the duration of ADP-induced ΔΨm depolarization,
which re-affirmed that ISO has inhibitory effects on complex III
(Fig. 4A,B). In this scenario it was likely that ISO, like AA, exerted
similar effects to inhibit complex III when SUC was the substrate with
complete inhibition of reverse electron transfer (RET) before adding
SUC. When ISO (or AA) was added, the duration of ΔΨm depolarization
increased because of slowed forward electron transfer (FET) to
complex IV from complex III (Fig. 1 and Fig. 7C). This slowing led to
the increases in the duration of state 3 ΔΨm depolarization.
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Fig. 4.

Normalized mitochondrial membrane potential (ΔΨm) during states 2, 3 and

4 respiration with SUC + ROT and either ISO or a blocker of ETC. ROT (1 μM) was
given before other drugs to maximally block complex I. ISO (A), AA (B), MAL (C), or
ATR (D) was added after SUC (A–D) and before adding ADP, which induced a transient
depolarization. The insets summarize effects of ISO compared to AA, MAL, and ATR on
duration of state 3 ADP-induced decreases in ΔΨm (S3 time, s). Note similarities and
differences of responses to each drug. ΔΨm transients were normalized with respect to
maximal (100%) depolarization obtained with added CCCP. Data represents
mean ± SD of 3 replicates.

However, it remained possible that ISO could also slow electron
transport at complex II since this was another site of electron
generation with SUC as the substrate. With complex I completely
blocked by ROT, and SUC as the only substrate, adding the complex II
inhibitor MAL (50–200 nM) resulted in only slight but not significant
increases in maximal state 3 ΔΨm depolarization (Fig. 4C) and state 3
duration (Fig. 4C inset). Because this is unlike the response of ISO to
the increased state 3 duration, we concluded that ISO has no
demonstrable effects on complex II.
We also examined if ANT is sensitive to ISO when complex I is
first blocked by ROT before adding the substrate SUC. Under
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conditions of SUC + ROT (1 μM), ISO increased the duration of state 3
ΔΨm; therefore we explored the possibility that this may result in part
from a decreased rate of ADP phosphorylation by attenuation of ANT
for translocation of ADP for ATP. With titrated low concentrations of
ATR (150 nM–3 μM), there was a concentration dependent decrease in
ADP-induced state 3 ΔΨm depolarization (Fig. 4D); but there was no
significant change in the duration of ADP phosphorylation because of
lesser exchange of ADP for ATP compared to the DMSO (vehicle)
group. The effects of ATR on OxPhos show that ATR incrementally
inhibited ANT. The variable responses between ISO and ATR suggested
and supported our previous observation that ISO does not have an
appreciable effect on ANT activity.

3.3. Effect of isoflurane vs. respiratory inhibitors on
mitochondrial O2 consumption
Time-dependent effects of DMSO (vehicle) and graded
concentrations of ISO, complex I (ROT), or complex III (AA) inhibitors
on O2 consumption rate in the presence of PM or SUC during states 2,
3 and 4 respirations are shown in Fig. 5A–F. The insets show
summaries of treatment effects on state 3 and state 4. With the
complex I substrate PM, ISO significantly slowed state 3 respiration
rate in a concentration-dependent manner: 183 ± 7 (0.5 mM ISO),
106 ± 8 (1 mM ISO), and 91 ± 8 (2 mM ISO) vs. 220 ± 6 (DMSO)
nmol·min− 1·mg− 1(Fig. 5A inset), with small decreases in state 4
respiration: 59 ± 7 (0.5 mM ISO), 44 ± 8 (1 mM ISO), and 32 ± 7
(2 mM ISO) vs. 32 ± 6 (DMSO) nmol·min− 1·mg− 1 (Fig. 5A inset). ISO
also prolonged the duration of state 3 respiration: 23 ± 4 s, 40 ± 6 s
and 49 ± 5 s at 0.5, 1 and 2 mM ISO, respectively, vs. 21 ± 6 s with
DMSO. Like ISO, low concentrations of ROT also caused concentrationdependent decreases in respiration and increases in state 3 duration
(Fig. 5B). These results are consistent with the effects of ISO and ROT
to decrease the magnitude and to increase the duration of NADH
oxidation (Fig. 2A,B). Unlike ISO and ROT, AA (in high concentrations)
with the substrate PM, caused a slight but significant decrease in
respiration rate (Fig. 5C inset) and duration of state 3 (Fig. 5C), which
are consistent with the small increases in the duration of state 3 NADH
oxidation and ΔΨm depolarization (Figs. 2C and 3C).
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Fig. 5.

Mitochondrial O2 concentration (nmol·min− 1) during states 2, 3 and 4

respiration with different substrates and either ISO or a blocker of ETC complexes.
ISO, ROT, or AA was added after PM (A–C) or SUC (D–F) and before ADP. Adding ADP
induced a transient depolarization. The insets summarize effects of added ISO, ROT
and AA on state 3 and state 4 respiration rates (nmol·min− 1·mg− 1protein). Note
similarities and differences of responses to each drug. Data represent mean ± SD of 3
replicates.

ISO did not significantly decrease state 3 respiration rate in a
concentration-dependent manner with complex II substrate SUC
(Fig. 5D). Unlike with the substrate PM, with substrate SUC, ISO
decreased state 3 duration: 63 ± 7 s, 60 ± 6 s and 59 ± 5 s at 0.5, 1
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and 2 mM ISO, respectively, vs.73 ± 4 s with DMSO. The effects of
ISO with substrate SUC (Fig. 5D) were compared with those of ROT
(Fig. 5E) and AA (Fig. 5F). In a concentration-dependent manner, ISO
decreased state 4 respiration rate, possibly by inhibiting complex I
with attenuation of RET from the reduced Q pool to complex I. The
effect of ISO to decrease state 4 respiration with substrate SUC was
again shown to result from attenuated complex I activity because
these results were consistent with the effect of ROT to decrease state
4 respiration (Fig. 2 D,E). Unlike ISO, adding AA (at higher
concentrations) caused an increase in state 3 respiration compared to
DMSO (Fig. 5D vs. F). The effects of ISO, ROT, and AA on
concentration-dependent changes in the duration of state 3 respiration
showed that responses to ISO closely matched those of ROT with SUC
as the substrate (Fig. 5D,E,F).
The effects of ISO and AA on respiration rates with SUC as the
substrate after complete block of complex I with high ROT (1 μM) were
compared (Fig. 6A,B) as was done for ΔΨm (Fig. 4A,B). ISO slightly,
but significantly, increased state 3 respiration: 120 ± 5 (DMSO),
128 ± 7 (0.5 ISO), 139 ± 6 (1 mM ISO) and 136 ± 7 (2 mM ISO)
nmol·min− 1·mg− 1; ISO induced a small but significant increase in state
4 respiration. In contrast, AA induced more pronounced increases in
state 3 respiration: 120 ± 8 (DMSO), 228 ± 8 (10 nM AA), 210 ± 8
(20 nM AA) and 213 ± 1 (25 nM AA) nmol·min− 1·mg− 1. AA also
increased state 4 respiration: 93 ± 8 (DMSO) 133 ± 6 (10 nM AA),
127 ± 7 (20 nM AA), 115 ± 7 (25 nM AA) nmol·min− 1·mg− 1 that could
be attributed to electron leak at the inhibited complex III site. Thus,
when complex I was completely blocked, electron transfer from
complex II to complex IV became attenuated as complex III was stepwise blocked. With blocked proton pumping at complex I and reduced
proton pumping at complexes III and IV, this tended to reduce the
redox state and ΔΨm (Fig. 4A,B), thus stimulating respiration. During
state 3 respiration with proton influx at complex V, respiration became
even faster until ΔΨm was restored.
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Fig. 6.

Mitochondrial O2 concentration (nmol·min− 1) during states 2, 3 and 4

respiration with substrate SUC and either ISO or a blocker (AA) of ETC complexes. ROT
(1 μM) was given before succinate to maximally block complex I and RET. The insets
summarize effects of added ISO, ROT, and AA on state 3 and state 4 respiration rates
(nmol·min− 1·mg− 1protein). Note similarities and differences of responses to each drug.
Data represent mean ± SD of 3 replicates.

4. Discussion
The mitochondrion has emerged as a key component in VAmediated cardioprotection against IR injury. VAs (e.g. ISO) could
provide cellular protection against IR injury, in part, by direct effects on
mitochondrial ETC. complexes or on other proteins (ANT) involved in
OxPhos that result in attenuated mitochondrial damage. Prior reports
indicate that VAs likely have depressant effects on mitochondrial
function [34], [35] and [36]. However, the specific targets and
mechanisms of VA action on mitochondrial respiration and
phosphorylation remain to be understood.
The aim of this study was to identify and characterize potential
targets of ISO in isolated cardiac mitochondria by monitoring changes
in bioenergetic variables (NADH, ΔΨm, and respiration) during states 2,
3 and 4 respiration. To do so we used different substrates (PM, SUC,
SUC + ROT) in the absence and presence of ISO to compare its effects
with ETC complex inhibitors (ROT, AA, MAL, KCN and OMN) or the ANT
inhibitor ATR, each given in ascending submaximal concentrations.
Overall, we found that ISO caused concentration-dependent differential
modulation of mitochondrial NADH, ΔΨm, and respiration under different
substrate conditions. Based on the responses and comparisons of ISO
and classical ETC inhibitors (Fig. 1) on different states of respiration, we
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concluded that complex I and complex III are specific respiratory protein
targets of ISO by comparing the bioenergetic effects of ISO with those
of classical inhibitors. In contrast, using the same approach, our data
suggests that ISO does not significantly impair the function of
complexes II, IV, V or ANT. The differential modulation of mitochondrial
function under different substrate conditions with ISO provides insights
into the more or less selective interaction of ISO with mitochondrial
proteins. These targets could have significant implications for the
mechanism of VA-induced protection against cardiac oxidative stress
and could also account, in part, for the mild negative inotropic effect of
VA's.

4.1. Isoflurane-induced differential
bioenergetics with substrate PM

modulation

of

Transient NADH oxidation to NAD+ during ADP-stimulated
respiration is due to a transient decrease in NADH secondary to
enhanced proton pumping and electron transfer to replace proton influx
via complex V (see Fig. 1). ISO and ROT exhibited very similar effects
to attenuate the magnitude and increase the duration of state 3 NADH
oxidation (Fig. 2A,B and insets). These effects are likely due to
restricted proton pumping by complex I so that proton entry into
complex V after adding ADP is slowed and prolonged. The ISO-induced
concentration-dependent decreases in NADH oxidation and increases in
state 3 NADH duration suggested that ISO attenuates the increases in
electron transfer and proton pumping induced by proton influx driven
ADP phosphorylation (Fig. 7A); these data were consistent with our
previous observation of partial inhibition of complex I by ISO [8]. The
low concentrations of ROT (20–80 nM), to mimic the effects of ISO, are
believed to partially block electron transfer (and so proton pumping)
between the NADH binding site via FeS centers and the Q binding site
in complex I. Although we deduced that ISO attenuates complex I
function in a similar manner, the concentrations of ISO required to
produce the same effect on complex I are about 103 higher; this may
indicate that the potency of ISO for an effect on the Q binding site of
complex I is very low or that the molecular mechanism of inhibition on
complex I is dissimilar (less specific) from that of ROT. For example,
although ROT, like ISO, increased the duration of state 3 ΔΨm
depolarization (Fig. 3A,B), ISO did not change the extent/magnitude of
depolarization, whereas ROT increased it substantially. These
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differential effects on the extent of maximal state 3 ΔΨm depolarization
and NADH oxidation by ISO and ROT appears to imply that ISO
attenuated complex I function somewhat differently than ROT. For
example, the ISO-induced increase in the duration of ADP
phosphorylation is most likely due to attenuation of proton pumping
downstream of complex I to better match the slower rates of electron
transfer and ADP phosphorylation due to inhibition of the complex. This
implies that ISO may have effects other than on complex I only.

Fig. 7.

Schema depicting ADP-induced changes in magnitude and duration of

mitochondrial bioenergetic variables (NADH, ΔΨm, respiration), and presumed changes
in electron transfer activity (ETA) along the ETC before and after ISO. ISO is compared
with ROT or AA to induce attenuation of complex I and complex III with NAD-linked
substrate PM (A), FAD-linked substrate SUC (B), and substrate SUC + ROT after
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complete inhibition of complex I with 1 μM ROT (C). Small arrows ( ) indicate the
relative number of electrons transported during FET before and after attenuation of
complex I or complex III. Broken arrows ( ) near complex I (CI) and complex III
(CIII) indicate mild inhibition of complexes and the solid arrow ( ) near complex I
indicates complete inhibition of complex I with ROT (1 μM). Complexes I–IV (CI–IV);
PM, K+-pyruvate/malate; SUC, K+-succinate; ISO, isoflurane; ROT, rotenone; AA,
antimycin A; FET, forward electron transfer; RET, reverse electron transfer.

ISO, like the complex III Qi site inhibitor AA [37], [38] and [39],
increased the duration of state 3 ΔΨm (Fig. 3A,C) implying that ISO
may attenuate complex III in addition to complex I. On the other
hand, ISO increased the duration of state 3 ΔΨm more than AA
(Fig. 3A,C). AA and ROT similarly prolonged the duration of state 3
ΔΨm (Fig. 3B,C) but did not exactly match the effect of ISO (Fig. 3A),
which again implicates complex III as another site of ISO action. The
ISO and AA-induced increases in duration of ADP phosphorylation most
likely result from attenuated proton pumping at complexes III and IV
downstream of complex I due to attenuated rates of electron transfer.
Note that because ISO appears to simultaneously inhibit complexes I
and III, the greater state 3 durations of NADH oxidation and ΔΨm
depolarization by ISO vs. AA may be due to ISO additionally inhibiting
complex I.
The net effect of proton influx at complex V with addition of ADP
(Fig. 1) is to temporarily depolarize the IMM and consume NADH as
respiration is enhanced to restore the ΔΨm and NADH (reducing
equivalents). ISO, ROT, and AA each slowed state 3 respiration
(Fig. 5A,B,C), presumably because of reduced electron transfer to
complex IV associated with decreased proton pumping at complexes I
and III. These results extend previous findings [8] and [23] that
suggested that the prolonged duration of state 3 ADP phosphorylation
can be attributed to slowed rates of electron transfer and proton
pumping by NADH-linked intermediates; this is consistent with the
increased duration of state 3 NADH, ΔΨm, and respiration with the
complex I substrate PM.
A decrease in ΔΨm can be caused by any protonophoric effect
that would allow ADP-independent influx of protons into the matrix
(proton leak) [40] and [41], which would increase respiration to
restore ΔΨm. We did not observe any ISO-mediated change in matrix
pH with BCECF-AM incubated mitochondria (data not shown), nor any
increase in state 2 respiration to support a proton leak (Fig. 5A).
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Indeed, during respiratory states 3 and 4 ISO slowed the rate of
respiration, which is not consistent with a proton leak (Fig. 5A).
A description of FET under these substrate conditions with ISO,
ROT, and AA is depicted in Fig. 1 and Fig. 7A. We postulate that the
mild inhibition of complex I with ROT or ISO decreases the NADHsupported transfer of electrons in the forward direction, i.e. from
complex I to complex III and to complex IV, and this results in
decreased ADP-induced NADH oxidation and increased state 3
durations of NADH oxidation, ΔΨm and respiration. The mild inhibition
of complex III with AA or ISO decreases transfer of electrons from
complex III to complex IV and this results in an increased duration of
state 3 ΔΨm depolarization, without affecting the magnitude of NADH
oxidation (Figs. 2C and 7A).

4.2. Isoflurane-induced differential modulation of
bioenergetics with substrate SUC
The complex II substrate (SUC) causes a reversal of the
standard reduction potential [25] so that NAD+ is reduced to NADH
through RET and this causes superoxide generation at complex I
[40] and [42]. Under these conditions ISO and ROT similarly
decreased the extent and duration of ADP-induced state 3 NADH
oxidation (Fig. 2D,E) and ΔΨm depolarization (Fig. 3D,E). These effects
resulted from a decreased rate of ADP phosphorylation because the
rate of state 3 respiration was actually slower with ISO and ROT
(Fig. 5 D,E). A description of slowed FET under these substrate
conditions with ISO, ROT or AA is depicted in Fig. 7B. Succinate can
generate NADH in complex I through RET, which is sensitive to
ΔΨm[43]. We interpret from our findings that mild inhibition of
complex I with ISO or ROT decreased RET supported generation of
NADH and subsequent oxidation of the available NADH resulted in
depressed state 3 respiration. The reduced extent and duration of
state 3 by ISO or ROT could be attributed to decreased RET-mediated
NADH generation and impaired oxidation of NADH due to attenuated
complex I function. However, this may not be a major contributing
factor since RET may be less favorable when Ψm is depolarized by the
added ADP. Therefore, an alternative possibility could be that impaired
oxidation of NADH induced by ISO and ROT could lead to a slowing of
the TCA cycle activity, thereby leading to accumulation of
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oxaloacetate, which inhibits complex II. Inhibition of complex II would
lead to a decrease in OxPhos capacity with SUC by lowering the ΔΨm
to result in a decrease in ROS production via oxidation of the
ubiquinone pool [44]. A description of slowed FET under these
substrate conditions with ISO, ROT and AA is depicted in Fig. 7B.
ISO or ROT-induced decreases in the extent and duration of
state 3 ΔΨm depolarization (Fig. 3 D,E) by attenuation of complex I at
the Q site would result in decreased NADH oxidation. The net result
would be an increase in reduced NADH and a shorter duration of NADH
oxidation, but decreases in states 3 and 4 respiration (Fig. 5D,E
insets). With the substrate PM, unlike the substrate SUC, the ISOinduced increase in duration of state 3 NADH oxidation support
inhibition of electron transfer from complex I. However, with the
substrate SUC, the marked decreases in the duration of state 3 ΔΨm
depolarization are more likely attributed either to a decrease in FET
from the reduced Q site of complex I to the Q pool, or to attenuation
of SUC-supported transfer of electrons from complex II by
oxaloacetate accumulation. The accumulation of oxaloacetate could
result from the inhibitory effect of ROT/ISO to reduce oxidation of
NADH during state 3 (Fig. 8). This ISO concentration-dependent effect
to decrease state 3 respiration diminishes the possibility that this is
due to blocking complex I electron transfer from the Q pool to complex
I or to attenuation of the redox between Q and QH; thus this effect
favors the possibility of attenuation in FET along the ETC as depicted in
Fig. 8. Moreover, because ISO or ROT depressed state 3 and state 4
respiration with the substrate SUC (Fig. 5D,E), this verifies that ISO
and ROT mediated attenuation of complex I function did not lead to an
increase in respiration as a result of proton leak at the inhibited
complex I. In mitochondria respiring on SUC, the increases in duration
of state 3 ΔΨm depolarization (Fig. 3F) after treatment with AA could
occur by impeding electron transfer from the SUC-driven reduced Q
pool to complex III.
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Fig. 8.

Schema depicting electron transfer from substrate SUC to downstream and

upstream complex I and complex III, respectively. Electrons from SUC pass through
FADH2 to the Q pool, which transfers electrons to the Q site of complex I. Within
complex I, electrons transferred to the Q site can either go in the reverse direction via
RET through FeS clusters and FMN to generate NADH from NAD+ or go in the forward
direction via FET to produce QH2; RET vs. FET is dependent on the standard reduction
potential across complex I. Binding of ISO, like ROT, may inhibit the transfer of
electrons from the QH2 of complex I to the Q pool to complex III. Solid arrows ( )
show electrons transported in the forward direction (FET) and broken arrows ( )
show electrons transported in the reverse direction (RET). Question marks (?) show
the possible indirect mechanisms of attenuation in FET either via attenuation of
electron transfer from the Q site of complex I to the Q pool, or succinate generated
accumulation of oxaloacetate due to ROT/ISO mediated decrease in NADH oxidation.

4.3. Isoflurane-induced differential modulation of
bioenergetics with substrate SUC and block of complex
I
ISO attenuates complex III function, as we deduced in part by
the similarity between ISO and AA on increasing the duration of state
3 ΔΨm depolarization with SUC after completely blocking complex I
with 1 μM ROT (Fig. 4A,B). Attenuation of complex III function with
inhibited FET and RET at complex I impedes FET from substrate SUC
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and could lead to electron leak and O2− generation [25]. The apparent
increases in states 3 and 4 respiration with SUC + ROT (Fig. 6A,B)
could be attributed to increased O2− generation, due to electron leak at
complex III with AA, rather than reduction of O2 to H2O [45]. The
effects of mild inhibition of complex III with ISO or AA to decrease
transfer of electrons from complex III to complex IV and to increase
the duration of state 3 ΔΨm depolarization is depicted in Fig. 7C.
We additionally explored the possibility that in the presence of
SUC + ROT the ISO-mediated increases in duration of state 3 ΔΨm
depolarization can be alternatively explained by an attenuating effect
of ISO on complex II or ANT function. But unlike ISO, which increased
the duration of ADP phosphorylation, low concentrations of ATR did not
significantly change state 3 ΔΨm duration (Fig. 4C,D). This implies that
ISO-mediated increases in state 3 duration are likely attributed to
attenuation of complex III rather than to attenuation of complex II
function or attenuation of transfer of ADP/ATP by ANT. The data
obtained on attenuation of complex IV function by KCN (data not
shown), and it's comparison by ISO, suggests that complex IV is also
not a potential target of ISO.
Because ISO induced small increases in states 2, 3, and 4
respiration (Fig. 6A) under the substrate SUC + ROT (1 μM), we tested
if ISO exhibited characteristics of proton leak (uncoupling) by
comparing the effects of low titrated concentrations of known
uncouplers (DNP, FCCP) to induce mitochondrial ΔΨm depolarization.
Compared to ISO, these uncoupling agents caused a pronounced state
2 depolarization (data not shown). In addition, matrix acidification and
ΔΨm depolarization are hallmarks of proton leak [41] and [46], but we
did not observe any change in matrix pH measured by BCECF
fluorescence (data not shown).

4.4. Isoflurane-induced effects on complexes I and III:
implication for cardioprotection
Volatile anesthetics protect the myocardium against IR injury, in
part, by modulating mitochondrial respiratory function [47],
[48] and [49] to mildly disrupt electron transfer and induce small
amount of ROS, which acts as a signaling molecule [11], [18],
[33] and [35]. In this current study, we concentrated on identifying
the direct effects of ISO on proteins involved in mitochondrial
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respiration, nucleotide transfer and OxPhos with the aim to better
understand how VAs modulate cardiac function and confer protection
against IR injury.
We proposed that ISO-mediated cardioprotection is initiated by
partial inhibition of at least several ETC protein components to cause
decreased electron transport and induce ROS production, which in turn
initiates cardioprotective pathways. Based on this and prior studies, we
believe it is plausible that ISO protects by attenuating complex I and
complex III activity to cause 1) release of small amounts of ROS at
complex I [50], [51] and [52] and complex III [53] and [54] during
the period before ischemia (APC) or after ischemia (APOC), and 2)
decrease in O2 consumption by reducing the workload during the
period of limited O2 availability during ischemia [55]. These events
could limit deleterious ROS generation during IR and so prevent
mitochondria from initiating apoptotic events leading to cell death. We
showed previously that limiting complex I activity during ischemia has
the potential to minimize accumulation of ROS on reperfusion and
therefore to protect mitochondria and the cell from oxidative damage
[19].
Notably, both complex I and complex III are targets but also
sites of ROS generation [45], [56] and [57]. The cardioprotective
effect of ISO against IR injury could also be triggered by a small rise in
ROS by its selective inhibition of ETC activity at complex I [50],
[51] and [52] and complex III [53] and [54]. Our study provides
useful information on effects of ISO on forward and backward electron
transfer pathways that modulate mitochondrial bioenergetics in a way
that may contribute to cardioprotection.
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